Cycloxygenase inhibition enhances the effects of surfactant therapy in endotoxin-induced rat model of ARDS

Inflammation

Volumn 34, Issue 2, 2011, Pages 92-98

  Mittal, Neha ^a   Sanyal, Sankar Nath ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

ARDS; COX 1; COX 2; SP A; Surfactant

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN E2; SURFACTANT PROTEIN A;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNOFLUORESCENCE; LUNG ALVEOLUS CELL TYPE 2; MALE; NONHUMAN; PROSTAGLANDIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

RATTUS; RODENTIA;

EID: 85028094797     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-010-9211-6     Document Type: Article

References (28)

1. Ware, L.B., and M.A. Matthay. 2000. The acute respiratory distress syndrome. The New England Journal of Medicine 342: 1334-1349. (Pubitemid 30408719)
2. Hallman, M., R. Spragg, and J. Harrel. 1982. Evidence of lung surfactant abnormalities in respiratory failure. Journal of Clinical Investigation 70: 673-683.
3. Gregory, T., W.J. Longmore, M.A. Moxley, and J.A. Whitsett. 1991. Surfactant chemical composition and the biophysical activity in the acute respiratory distress syndrome. Journal of Clinical Investigation 88: 1976-1981.
4. Fine, A., Y. Janssen-Heininger, R.P. Soultanakis, S.G. Swisher, and B.D. Uhal. 2000. Apoptosis in lung pathophysiology. American Journal of Physiology. Lung Cellular and Molecular Physiology 279: L423-L427.
5. Sutherland, L.M., Y.S. Edwards, and A.W. Murray. 2001. Alveolar type II cell apoptosis. Comparative Biochemistry and Physiology. Part A: Molecular & Integrative Physiology 129: 267-285. (Pubitemid 32455724)
6. Fink, M.P. 2001. Prostaglandins and sepsis: Still a fascinating topic despite almost 40 years of research. American Journal of Physiology. Lung Cellular and Molecular Physiology 281: L534-L536. (Pubitemid 32879203)
7. Smith, W.L. 1992. Prostanoid biosynthesis and mechanisms of action. The American Journal of Physiology 263: F181-F191.
8. Groeneveld, A.B. 2002. Vascular pharmacology of acute lung injury and acute respiratory distress syndrome. Vascular Pharmacology 39: 247-256. (Pubitemid 37490750)
9. Arias-Diaz, J., E. Vara, C. Garcia, and J.L. Balibrea. 1994. Tumor necrosis factor-alpha-induced inhibition of phosphatidylcholine synthesis by human type II pneumocytes is partially mediated by prostaglandins. Journal of Clinical Investigation 94: 244-250.
10. Sanchez-Alcazar, J.A., D.A. Bradbury, L. Pang, and A.J. Knox. 2003. Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways. Lung Cancer 40: 33-44. (Pubitemid 36344064)
11. Malloy, J.L., and J.R.Wright. 2004. In vivo clearance of surfactant lipids during acute pulmonary inflammation. Respiratory Research 5: 1-9.
12. Suzuki, Y., E-ichi Nakai, and K-ichi Ohkawa. 1982. Experimental studies on the pulmonary surfactant. Reconstitution of surface active material. Journal of Lipid Research 23: 53-61. (Pubitemid 12112612)
13. Raczka, E., J.F. Kukowska-Latallo,M. Rymaszewski, C. Chen, and J. R. Baker Jr. 1998. The effect of synthetic surfactant exosurf on gene transfer in mouse lung in vivo. Gene Therapy 5: 1333-1339.
14. Chabot, S., L. Salez, X. Francis, T.L. McCormack, and M. Chignard. 2003. Surfactant protein A inhibits lipopolysaccharide-induced in vivo production of interleukin-10 by mononuclear phagocytes during lung inflammation. American Journal of Respiratory Cell and Molecular Biology 28: 347-353. (Pubitemid 36238012)
15. Richards, R.J., N. Davies, L. Atkins, and V.I. Oreffo. 1987. Isolation, biochemical characterization, and culture of lung type II cells of the rat. Lung 165: 143-158. (Pubitemid 17083611)
16. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72: 248-254.
17. Fukunaga, K., P. Kohli, C. Bonnans, L.E. Fredenburgh, and B.D. Levy. 2005. Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. Journal of Immunology 174: 5033-5039.
18. Saito, T., I.W. Rodger, F. Hu, R. Robinson, T. Huynh, and A. Giaid. 2004. Inhibition of COX pathway in experimental myocardial infarction. Journal of Molecular and Cellular Cardiology 37: 71-77. (Pubitemid 38900530)
19. Masferrer, J.L., B.S. Zweifel, P.T. Manning, S.D. Hauser, K.M. Leahy, W.G. Smith, P.C. Isakson, and K. Seibert. 1994. Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic. Proceedings of the National Academy of Sciences of the United States of America 91: 3228-3232. (Pubitemid 24130209)
20. Gilroy, D.W., P.R. Colville-Nash, D. Willis, J. Chivers, M.J. Paul- Clark, and D.A. Willoughby. 1999. Inducible cyclooxygenase may have anti-inflammatory properties. Natural Medicines 5: 698-701. (Pubitemid 29289435)
21. Hempel, S.L., M.M. Monick, and G.W. Hunninghake. 1994. Lipopolysaccharide a prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. Journal of Clinical Investigation 93: 391-396. (Pubitemid 24030860)
22. Ermert, L., M. Ermert, M. Goppelt-Struebe, D. Walmrath, F. Grimminger, W. Steudel, H.A. Ghofrani, C. Homberger, H.R. Duncker, and W. Seeger. 1998. Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. American Journal of Respiratory Cell and Molecular Biology 18: 479-488. (Pubitemid 128353621)
23. Ingenito, E.P., R. Mora, L.A. Sonna, M. Cullivan, Y. Marzan, K. Halley, and L. Mark. 2001. Decreased surfactant protein B expression and surfactant dysfunction in a murine model of acute lung injury. American Journal of Respiratory Cell and Molecular Biology 25: 35-44. (Pubitemid 32682703)
24. Ingenito, E.P., R. Mora, L.H. Sonna, M. Cullivan, Y. Marzan, and K. Haley. 1999. Reduced SP-B protein and mRNA levels correlate with surfactant dysfunction in a murine model of acute lung injury. American Journal of Respiratory and Critical Care Medicine 159: A159 (Abstr.).
25. Mark, L., and E.P. Ingenito. 1999. Surfactant function and composition after free radical exposure generated by transition metals. American Journal of Physiology. Lung Cellular and Molecular Physiology 276: L491-L500. (Pubitemid 29159539)
26. Sugahara, K., K. Iyama, K. Sano, Y. Kuroki, T. Akino, and M. Matsumoto. 1996. Overexpression of surfactant protein SP-A, SP-B, and SP-C in rats with LPS-induced lung injury. Laboratory Investigation 74: 209-220. (Pubitemid 26041023)
27. McIntosh, J.C., A.H. Swyers, J.H. Fisher, and J.R. Wright. 1996. Surfactant proteins A and D increase in response to intratracheal lipopolysaccharide. American Journal of Respiratory Cell and Molecular Biology 15: 509-519. (Pubitemid 126440578)
28. Schochett, P., R. Mora, L. Mark, M. Butler, and E.P. Ingenito. 1999. Calcium dependent degradation of surfactant protein A by activated neutrophils due to serine proteases. Experimental Lung Research 25: 595-616. (Pubitemid 29517668)